So far, the Pfizer-BioNTtech and Moderna vaccines, made through a novel platform technology never used in humans before, are proven to have maximum efficacy

India's fuel demand to rise 9.8% in year to March 2022 India's fuel consumption could rise by 9.8% in the year to March 2022, its highest pace of growth in six years, driven by robust demand for gasoline and gasoil in Asia's third largest economy, according to initial government projections. Higher expectation of fuel consumption, a proxy for oil demand, points to a sharp recovery in industrial activity in the economy hit hard by the pandemic. Economic recovery lost steam in Jan-Feb: Axis...

\"The UK has ordered 100 million doses of AstraZeneca's COVID-19 vaccine, of which 10 million doses will come from the Serum Institute of India,\" a UK government spokesperson told Reuters

According to the researchers, the dosage regimen is beneficial while vaccine supplies are initially limited

The vaccines currently approved for emergency use in India are Covishield, from the Oxford-AstraZeneca stable manufactured by Pune's Serum Institute of India, and Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology (NIV)

China shared the genetic sequence with WHO in early January. However, scientists studying the origin had indicated that the virus might have been spreading long before it was officially reported

Scientists are working with an anti-viral coating technology called DiOX, which uses organic disinfectant compounds in the textiles, says report

The Anglo-Swedish drugmaker worked with Oxford to develop one of the first COVID-19 vaccines authorised for widespread use. AstraZeneca said it hopes to cut the time needed to produce large amounts of any new vaccine to between six and nine months

WHO highlighted the need to reduce virus circulation and prevent infections so that it reduces the opportunities for coronavirus to mutate further.

The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants carrying the N501Y and E484K mutations

The enhanced trade partnership is expected to address several trade barriers that currently exist. Britain is keen to see India reduces barriers on import of agriculture and food items

Adani Group completes acquisition of 23.5% stake in Mumbai Airport; to hike ownership to 74% Billionaire Gautam Adani-led Adani Group has completed acquisition of 23.5 per cent equity stake in Mumbai International Airport Limited (MIAL) from Airports Company South Africa (ACSA) and Bid Services Division (Mauritius) Limited for Rs 1,685.2 crore. The Indian multinational conglomerate is set to extend shareholding to 74 per cent in MIAL, a joint venture between the Airports Authority of India ...

Coronavirus vaccine: Sarah Gilbert, professor of vaccinology at Oxford told BBC that the researchers have already started working on the first part of the manufacturing process

Oxford University scientists who developed the ChAdOx1-nCoV19 vaccine have found that it remains effective against at least one of the new variants of the disease, called the B.1.1.7 'Kent' coronavirus strain

The study, carried out by the University of Sheffield in the UK, is the largest global review of factors associated with distress amongst health care workers during an infectious disease outbreak

A study from South Africa's University of the Witwatersrand and Oxford University showed the vaccine had significantly reduced efficacy against the South African variant

Andrew Pollard of Oxford University, which helped develop the AstraZeneca vaccine, says the shot also appears to reduce the amount of virus in people infected with COVID-19

The study, published in the journal Science of The Total Environment, noted that the southern Chinese Yunnan province and neighbouring regions in Myanmar and Laos form a global hotspot of climate change-driven increase in bat richness

The BT MindRush theme, Post-Pandemic Paradigm, brought out how businesses evolved in possibly their toughest year ever

The yet-to-be peer-reviewed study, posted in the preprint repository medRxiv, assessed the antibody responses in 109 individuals with and without documented pre-existing immunity to the novel coronavirus